Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector
Suma Athreye,
Dinar Kale () and
Shyama Ramani ()
Additional contact information
Dinar Kale: Open University, and ESRC Innogen
No 2008-041, MERIT Working Papers from United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT)
Abstract:
This paper demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.
Keywords: International Marketing; R&D Management; India; Pharmaceutical Sector; Corporate Strategy (search for similar items in EconPapers)
JEL-codes: L11 L22 L51 L65 M31 O32 O34 O53 (search for similar items in EconPapers)
Date: 2008
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (8)
Downloads: (external link)
https://unu-merit.nl/publications/wppdf/2008/wp2008-041.pdf (application/pdf)
Related works:
Journal Article: Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector (2009) 
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:unm:unumer:2008041
Access Statistics for this paper
More papers in MERIT Working Papers from United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) Contact information at EDIRC.
Bibliographic data for series maintained by Ad Notten ( this e-mail address is bad, please contact ).